TheWell Bioscience has become the newest tenant at a life science incubator owned by the New Jersey Economic Development Authority.
From its new location at the Commercialization Center for Innovative Technologies in North Brunswick, the biotechnology company will further develop and scale its 3D cell culture hydrogel system for drug screening, tissue engineering and pre-clinical applications.
“We have found New Jersey to be the perfect spot for our company,” John Huang, CEO of TheWell Bioscience, said. “Because it’s one of the biggest biopharmaceutical hubs in the country, the Garden State offers us access to a large pool of talented scientists and opportunities to provide service to more than a dozen of the world’s largest pharmaceutical companies.”
The 900-square-foot private lab at CCIT was an ideal fit for TheWell Bioscience after it had outgrown a shared workspace in Newark, it said.
“We love to hear about New Jersey startups growing and choosing to expand within New Jersey’s innovation ecosystem, particularly at a leading life sciences incubator like CCIT,” NJEDA CEO Tim Sullivan said. “Supporting innovative early-stage companies with affordable lab and office space is a strategic element in Governor Phil Murphy’s plan to reclaim New Jersey’s role as a leader in innovation. CCIT tenants have a long history of impacting the global marketplace and we look forward to what’s in store for TheWell Bioscience in the years to come.”
The 46,000-square-foot CCIT incubator offers 27 wet labs and is currently home to nearly two-dozen businesses.
